Skip to main content
Mitchell Olman, MD, Pulmonology, Cleveland, OH, Cleveland Clinic

MitchellAOlmanMD

Pulmonology • Cleveland, OH

Critical Care Medicine, Pleural Disease

Cell research

Join to view full profile

Dr. Olman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Olman's full profile

Already have an account?

Education & Training

  • University of Chicago
    University of ChicagoFellowship, Pulmonary Disease and Critical Care Medicine, 1986 - 1987
  • University of Chicago
    University of ChicagoResidency, Internal Medicine, 1983 - 1986
  • New York University School of Medicine
    New York University School of MedicineClass of 1983

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1987 - Present
  • OH State Medical License
    OH State Medical License 2009 - 2026
  • AL State Medical License
    AL State Medical License Active through 2009
  • IL State Medical License
    IL State Medical License 1983 - 1987
  • American Board of Internal Medicine Internal Medicine

Publications & Presentations

PubMed

Press Mentions

  • Mechanical Signaling Cascade Central to Fibrotic Scar Tissue Development Defined
    Mechanical Signaling Cascade Central to Fibrotic Scar Tissue Development DefinedNovember 13th, 2019
  • TRPV4 Regulates the Host Defense Response to Infection
    TRPV4 Regulates the Host Defense Response to InfectionMay 24th, 2018

Grant Support

  • Deranged Coagulation And Fibrinolytic Cascades In Idiopathic Pulmonary FibrosisNational Heart, Lung, And Blood Institute2010–2012
  • Mechanisms Of U-Par-Mediated Lung Fibroblast MotilityNational Heart, Lung, And Blood Institute2004–2007
  • Mechanisms Of PAI1 Regulation By Lung Matrix MoleculesNational Heart, Lung, And Blood Institute1999–2003
  • Scleroderma Lung StudyNational Heart, Lung, And Blood Institute1999–2001
  • Oral Cyclophosphamide VS Oral Placebo In SSC AlveolitisNational Heart, Lung, And Blood Institute2000

Hospital Affiliations

Dr. Mitchell Olman, Dr. Mitchell Olman, MD, Dr. M Olman, Dr. Mitchell A Olman